VS-7375 (GFH375)
Product Specifications
Target
Ras
Applications
Apoptosis
Additionnal Information
VS-7375 (GFH375) is an oral small-molecule inhibitor that selectively targets KRAS G12D in both its active (GTP-bound) and inactive (GDP-bound) forms. This dual-state inhibition results in stronger tumor suppression compared to single-state inhibitors. It exhibits potent anti-proliferative and anti-tumor effects in KRAS G12D-mutant models, including an intracranial GP2D tumor model.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
350572 100 µg
CD26, CT (DPP4, Dipeptidyl-peptidase 4, ADABP, Adenosine deaminase complexing protein 2, Dipeptidyl peptidase IV, T-cell activation antigen CD26, TP103)
Sign In for Pricing
View Details ARP53293_P050-Biotin 100 µL
TRAPPC5 Antibody - middle region : Biotin (ARP53293_P050-Biotin)
Sign In for Pricing
View Details